Cargando…
Inhibition of Oxidative Stress-Elicited AKT Activation Facilitates PPARγ Agonist-Mediated Inhibition of Stem Cell Character and Tumor Growth of Liver Cancer Cells
Emerging evidence suggests that tumor-initiating cells (TICs) are the most malignant cell subpopulation in tumors because of their resistance to chemotherapy or radiation treatment. Targeting TICs may be a key innovation for cancer treatment. In this study, we found that PPARγ agonists inhibited the...
Autores principales: | Liu, Lanlan, Yang, Zhaojuan, Xu, Yingqian, Li, Jingyi, Xu, Dongxu, Zhang, Li, Sun, Jiabin, Xia, Suhua, Zou, Feiyan, Liu, Yongzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758331/ https://www.ncbi.nlm.nih.gov/pubmed/24023668 http://dx.doi.org/10.1371/journal.pone.0073038 |
Ejemplares similares
-
Amplified Inhibition of Stellate Cell Activation Pathways by PPAR-γ, RAR and RXR Agonists
por: Sharvit, Efrat, et al.
Publicado: (2013) -
Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis
por: Liu, Chang, et al.
Publicado: (2015) -
PPARγ agonists inhibit growth and expansion of CD133+ brain tumour stem cells
por: Chearwae, W, et al.
Publicado: (2008) -
Corrigendum: Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis
por: Liu, Chang, et al.
Publicado: (2015) -
Transient mTOR Inhibition Facilitates Continuous Growth of Liver Tumors by Modulating the Maintenance of CD133+ Cell Populations
por: Yang, Zhaojuan, et al.
Publicado: (2011)